219 related articles for article (PubMed ID: 23656271)
41. The surgical treatment and outcome for primary duodenal adenocarcinoma.
Han SL; Cheng J; Zhou HZ; Zeng QQ; Lan SH
J Gastrointest Cancer; 2010 Dec; 41(4):243-7. PubMed ID: 20431961
[TBL] [Abstract][Full Text] [Related]
42. [Evaluation of curative and palliative treatment of duodenal adenocarcinoma].
Bendixen M; Dahl S; Fristrup C; Mortensen MB
Ugeskr Laeger; 2010 May; 172(18):1376-9. PubMed ID: 20444409
[TBL] [Abstract][Full Text] [Related]
43. Pancreas preserving distal duodenectomy: A versatile operation for a range of infra-papillary pathologies.
Mitchell WK; Thomas PF; Zaitoun AM; Brooks AJ; Lobo DN
World J Gastroenterol; 2017 Jun; 23(23):4252-4261. PubMed ID: 28694665
[TBL] [Abstract][Full Text] [Related]
44. Prognostic factors for primary duodenal adenocarcinoma.
Lee HG; You DD; Paik KY; Heo JS; Choi SH; Choi DW
World J Surg; 2008 Oct; 32(10):2246-52. PubMed ID: 18668288
[TBL] [Abstract][Full Text] [Related]
45. Primary adenocarcinoma of third and fourth portions of duodenum. Favorable prognosis after resection.
Lowell JA; Rossi RL; Munson JL; Braasch JW
Arch Surg; 1992 May; 127(5):557-60. PubMed ID: 1349472
[TBL] [Abstract][Full Text] [Related]
46. Number of involved lymph nodes is important in the prediction of prognosis for primary duodenal adenocarcinoma.
Liang TJ; Wang BW; Liu SI; Chou NH; Tsai CC; Chen IS; Yeh MH; Chen YC; Chang PM; Mok KT
J Chin Med Assoc; 2012 Nov; 75(11):573-80. PubMed ID: 23158035
[TBL] [Abstract][Full Text] [Related]
47. Fourteen year surgical experience of gallbladder cancer: validity of curative resection affecting survival.
Choi SB; Han HJ; Kim CY; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
Hepatogastroenterology; 2012; 59(113):36-41. PubMed ID: 22251521
[TBL] [Abstract][Full Text] [Related]
48. Pancreaticoduodenectomy: a 20-year experience in 516 patients.
Schmidt CM; Powell ES; Yiannoutsos CT; Howard TJ; Wiebke EA; Wiesenauer CA; Baumgardner JA; Cummings OW; Jacobson LE; Broadie TA; Canal DF; Goulet RJ; Curie EA; Cardenes H; Watkins JM; Loehrer PJ; Lillemoe KD; Madura JA
Arch Surg; 2004 Jul; 139(7):718-25; discussion 725-7. PubMed ID: 15249403
[TBL] [Abstract][Full Text] [Related]
49. The surgical treatment and outcome for primary duodenal adenocarcinoma.
Han SL; Cheng J; Zhou HZ; Zeng QQ; Lan SH
J Gastrointest Cancer; 2008; 39(1-4):46-50. PubMed ID: 19399645
[TBL] [Abstract][Full Text] [Related]
50. Superior prognostic importance of perineural invasion vs. lymph node involvement after curative resection of duodenal adenocarcinoma.
Cecchini S; Correa-Gallego C; Desphande V; Ligorio M; Dursun A; Wargo J; Fernàndez-del Castillo C; Warshaw AL; Ferrone CR
J Gastrointest Surg; 2012 Jan; 16(1):113-20; discussion 120. PubMed ID: 22005894
[TBL] [Abstract][Full Text] [Related]
51. Retrospective analysis of 119 small bowel adenocarcinoma in Chinese patients.
Guo XC; Mao ZY; Su D; Wang LJ; Zhang TT; Bai L
Cancer Invest; 2014 Jun; 32(5):178-83. PubMed ID: 24654694
[TBL] [Abstract][Full Text] [Related]
52. [Treatment of 54 cases of primary malignant duodenal tumor].
Sun JJ; Wu ZY
Zhonghua Wai Ke Za Zhi; 2004 Mar; 42(5):276-8. PubMed ID: 15062015
[TBL] [Abstract][Full Text] [Related]
53. Survival outcomes after surgical management of sporadic or familial adenomatous polyposis associated duodenal cancer.
Augustin T; Moslim MA; Cengiz TB; El-Hayek K; Simon R; Bhatt A; Tang A; Burke CA; Matthew Walsh R
J Surg Oncol; 2020 Nov; 122(6):1132-1144. PubMed ID: 33124067
[TBL] [Abstract][Full Text] [Related]
54. Pancreatic invasion as the prognostic indicator of duodenal adenocarcinoma treated by pancreatoduodenectomy plus extended lymphadenectomy.
Ohigashi H; Ishikawa O; Tamura S; Imaoka S; Sasaki Y; Kameyama M; Kabuto T; Furukawa H; Hiratsuka M; Fujita M; Hashimoto T; Hosomi N; Kuroda C
Surgery; 1998 Sep; 124(3):510-5. PubMed ID: 9736903
[TBL] [Abstract][Full Text] [Related]
55. Outcomes of surgical resection for primary duodenal adenocarcinoma: A systematic review.
Li D; Si X; Wan T; Zhou Y
Asian J Surg; 2019 Jan; 42(1):46-52. PubMed ID: 29802028
[TBL] [Abstract][Full Text] [Related]
56. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
Benassai G; Mastrorilli M; Mosella F; Mosella G
J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
[TBL] [Abstract][Full Text] [Related]
57. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis.
Wang HS; Liang WY; Lin TC; Chen WS; Jiang JK; Yang SH; Chang SC; Lin JK
Dis Colon Rectum; 2005 Jun; 48(6):1182-92. PubMed ID: 15793641
[TBL] [Abstract][Full Text] [Related]
58. Combined pancreaticoduodenectomy and hepatectomy for patients with locally advanced gallbladder carcinoma: long term results.
Shirai Y; Ohtani T; Tsukada K; Hatakeyama K
Cancer; 1997 Nov; 80(10):1904-9. PubMed ID: 9366291
[TBL] [Abstract][Full Text] [Related]
59. Adjuvant concurrent chemoradiation for node-positive adenocarcinoma of the duodenum.
Swartz MJ; Hughes MA; Frassica DA; Herman J; Yeo CJ; Riall TS; Lillemoe KD; Cameron JL; Donehower RC; Laheru DA; Hruban RH; Abrams RA
Arch Surg; 2007 Mar; 142(3):285-8. PubMed ID: 17372054
[TBL] [Abstract][Full Text] [Related]
60. Surgical management and outcome in primary adenocarcinoma of the small bowel.
Agrawal S; McCarron EC; Gibbs JF; Nava HR; Wilding GE; Rajput A
Ann Surg Oncol; 2007 Aug; 14(8):2263-9. PubMed ID: 17549572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
